Mijke Buitinga1,2, Julian Mevenkamp1, Florian Haans1, Kim Brouwers1, Patrick Schrauwen2, Lucas Lindeboom1,2, Joachim E Wildberger1, and Vera B Schrauwen-Hinderling1,2
1Department of Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 2Department of Nutrition & Movement Sciences, University of Maastricht, Maastricht, Netherlands
Synopsis
We have developed a novel 3T 1H-MRS sequence to detect acetylcarnitine. Acetylcarnitine has been investigated by 1H-MRS in the muscle and is thought
to play an important role in maintaining metabolic flexibility and insulin
sensitivity. As these are
hallmarks of metabolic disease, techniques to study acetylcarnitine levels
non-invasively are of great interest. The advantage of our approach is the
absence of a subtraction scheme and high signal intensity, while both water
and lipid resonances are sufficiently suppressed to uncover the acetylcarnitine
resonance. This makes our sequence suitable also for detection in tissues susceptible
to respiratory motion, such as the liver.
Introduction
The conversion
of excessive acetyl-coA into acetylcarnitine has been suggested to play an
important role in maintaining metabolic flexibility and insulin sensitivity
under conditions of excessive substrate supply to the mitochondria.1,2 As decreased metabolic flexibility and insulin sensitivity
are early indicators of the development of metabolic disease, such as type 2
diabetes mellitus (T2D)3 and non-alcoholic
fatty liver disease (NAFL)4, the development of non-invasive techniques
to quantitatively assess acetylcarnitine concentrations in vivo, are of
great interest. We previously quantified acetylcarnitine levels by 3T 1H-MRS
in skeletal muscle of healthy and metabolically compromised individuals5,6. Our results in skeletal
muscle clearly support the premise that acetylcarnitine concentrations
associate with insulin sensitivity. To further unravel the role of
acetylcarnitine in the development of metabolic diseases, we sought to develop
a 1H-MRS sequence that enables the study of this metabolite in the
liver. Reliable detection of acetylcarnitine by MRS techniques is hampered by
overlapping broad lipid resonances, Our previously developed editing sequences made
use of differences in spin-lattice (T1) and transversal (T2)
relaxation times between acetylcarnitine and lipids5,6. The most
effective lipid suppression was obtained by a subtraction-based T1
editing approach with a long TE of 350ms6. However, as the
liver moves with respiration, such a subtraction-based method is sensitive to
motion-induced artifacts and therefore infeasible. Here, we propose a
single-shot approach with dual water/lipid suppression based on the variable
pulse power and optimized relaxation delays (VAPOR) scheme.Methods
The VAPOR scheme is originally designed to only suppress
water7. The advantage of
the VAPOR sequence is its relative insensitivity to inhomogeneities in transmit
B1 field of the RF coil and variations in T1. The
original sequence consists of eight frequency-selective RF pulses of which the
timing and flip angles were optimized to null a large range of water T17.
To get dual
water and lipid suppression, two of the RF pulses were exchanged for
inversion
pulses (BW75Hz) of which the frequency was set at the acetylcarnitine
region. The timing of the two inversion pulses and the timing and
relative
flip angles of the remaining six VAPOR pulses were optimized through
computer
simulations in MATLAB (MATLAB 2018b, The
MathWorks,Inc.). The
voxel used was 40mm x 20mm x 60mm. All spectra were acquired with a TR
of 7500ms, TE of 266ms, number of acquired data points of 2048, and
number of averages
(NSA) of 16. The TE equals 2/Jα-carbonyl and was chosen to
refocus J-coupling of α-carbonyl, the resonance closest to
acetylcarnitine. The
optimized sequence with the simulations are depicted in figure 1. To
test the MRS sequence, we acquired 1H-MRS spectra (Achieva 3T MRI,
Philips Health Care) of phantoms with 10% intralipid (a
soybean oil emulsion (Fresenius Kabi)) in physiological salt including
0mM,
2mM, or 5mM of acetylcarnitine (Sigma Aldrich) and 2% agar (Invitrogen).
A regular
PRESS with a TE of 266ms and without water and lipid suppression was
acquired
to use the unsuppressed water signal as an internal reference. To assess
the
performance of our newly developed sequence (iVAPOR) in comparison to
the
formerly established sequences for the muscle, we also acquired spectra
with
the subtraction-based T1 editing sequence with a TE of 350ms6. All obtained spectra were post-processed in a custom-written MATLAB
script as previously described8. Acetylcarnitine content was calculated after T2
correction relative to the unsuppressed water resonance.Results
The PRESS spectrum of the phantom with 10% intralipid
and 5mM acetylcarnitine (figure 2a) clearly demonstrates the broad lipid
resonances that overlap the acetylcarnitine resonance when no lipid suppression
is applied. The acetylcarnitine peaks could be revealed in the phantoms
containing 2mM and 5mM acetylcarnitine by supressing the lipid resonances using
either the subtraction-based T1 editing sequence (figure 2b) or the iVAPOR
sequence (figure 2c). Due to the lower TE of the iVAPOR sequence, the signal
intensity of the acetylcarnitine peak was higher (figure 2c) when compared with
the acetylcarnitine peak obtained with the subtraction-based T1
editing sequence (figure 2b). Integration of the peaks resulted in comparable
values when corrected for T2 decay, indicating that both methods
work effectively. Measured acetylcarnitine levels by the iVAPOR sequence strongly
correlated with the known phantom concentrations.Discussion and Conclusion
Our iVAPOR approach allows the detection of
acetylcarnitine in a single-shot, circumventing subtraction artifacts
associated with our T1 editing sequence6. The use of inversion pulses makes the iVAPOR approach intrinsically
more sensitive to variations in T1 relaxation times, though the absence
of a subtraction scheme and a higher signal intensity make this sequence more
suitable for detection in tissues susceptible to respiratory motion, such as
the liver. Future
studies should focus on reproducibility measurements and in vivo
validation steps in the muscle and liver.Acknowledgements
No acknowledgement found.References
1. Noland RC,
Koves TR, Seiler SE, et al. Carnitine insufficiency caused by aging and
overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem. 2009;284(34):22840-22852.
doi:10.1074/jbc.M109.032888
2. Muoio DM,
Noland RC, Kovalik JP, et al. Muscle-specific
deletion of carnitine acetyltransferase compromises glucose tolerance and
metabolic flexibility. Cell Metab. 2012;15(5):764-777.
doi:10.1016/j.cmet.2012.04.005
3. Czech MP.
Insulin action and resistance in obesity and type 2 diabetes. Nat Med.
2017;23(7):804-818. doi:10.1038/nm.4350.Insulin
4. Manco M.
Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics. Children.
2017;4(8):74. doi:10.3390/children4080074
5. Lindeboom
L, Nabuurs CI, Hoeks J, et al. Long-echo time MR spectroscopy for skeletal
muscle acetylcarnitine detection. J Clin Invest. 2014;124(11):4915-4925. doi:10.1172/JCI74830
6. Lindeboom
L, Bruls YMH, van Ewijk PA, et al. Longitudinal
relaxation time editing for acetylcarnitine detection with 1H-MRS. Magn
Reson Med. 2017;77(2):505-510. doi:10.1002/mrm.26149
7. Tkáč I,
Deelchand D, Dreher W, et al. Water and lipid suppression techniques for
advanced 1H MRS and MRSI of the human brain: Experts’ consensus
recommendations. NMR
Biomed. 2021;34(5):1-25.
doi:10.1002/nbm.4459
8. Roumans
KHM, Lindeboom L, Veeraiah P, et al. Hepatic
saturated fatty acid fraction is associated with de novo lipogenesis and
hepatic insulin resistance. Nat Commun. 2020;11(1):1-11.
doi:10.1038/s41467-020-15684-0